Nutex Health Shares Surge 7.4% Amid Positive Analyst Outlook

Analysts see potential in the integrated outpatient healthcare services company's growth strategy.

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

Shares of Nutex Health Inc. (NASDAQ:NUTX) traded 7.4% higher on Wednesday, reaching as high as $105.50 per share. The surge comes as Wall Street analysts have issued a 'Moderate Buy' rating on the stock, with a consensus price target of $252.50. Nutex Health is an integrated outpatient healthcare services company based in San Antonio, Texas, focused on delivering a range of ambulatory care solutions including urgent care, telemedicine, medical imaging, and behavioral health support.

Why it matters

Nutex Health's integrated model of combining in-person clinics with virtual care capabilities aims to provide patients with more accessible and cost-effective treatment options outside of traditional hospital settings. The company's strong performance and positive analyst outlook suggest its strategy is resonating in the market and could signal growth opportunities in the outpatient healthcare services space.

The details

Nutex Health shares traded as high as $105.50 on Wednesday before closing at $106.4950, up 7.4% on the day. Trading volume was down 87% from the average session, with 24,171 shares changing hands. Wall Street analysts have issued a 'Moderate Buy' rating on the stock, with a consensus price target of $252.50. The company operates an urgent care network through standalone and retail-anchored centers, offering treatment for non-life-threatening injuries and illnesses, preventive screenings, and basic primary care.

  • Nutex Health shares traded up 7.4% on Wednesday, February 28, 2026.

The players

Nutex Health Inc.

An integrated outpatient healthcare services company based in San Antonio, Texas, focused on delivering a range of ambulatory care solutions including urgent care, telemedicine, medical imaging, and behavioral health support.

Wall Street Zen

A financial research firm that raised its rating on Nutex Health from 'buy' to 'strong-buy' in a report on November 28th.

Weiss Ratings

A ratings agency that maintained a 'hold (c)' rating on Nutex Health in a research report on December 29th.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

Nutex Health's integrated outpatient care model and positive analyst sentiment suggest the company is well-positioned to capitalize on growing demand for accessible, cost-effective healthcare services outside of traditional hospital settings. The stock's recent surge could signal further upside potential for investors if the company continues to execute on its growth strategy.